Can anyone explain what happens to PPHM’s poison pill in the event of a 1 for 10 reverse split?
Assuming: 1) one or more BP is familiar with SK and PPHM but are waiting on final results from ongoing and pending Phase II clinical trials before making a commitment; and 2) PPHM, because of the successful expansion of Avid, has decided to “go it alone” with Phase III clinical trials.
A situation could exist whereby PPHM would need the protection of the poison pill. If the PP was removed by the R/S could the BP accomplish a hostile takeover to the detriment of shareholders? If the PP remains, PPHM's decision to "go it alone" puts the company in a much stronger bargaining position.
Market Data 
Markets 
AI
